相关实验视频

Updated: May 13, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.0K

与对照新生儿相比,治疗性低温的新生儿的数学白蛋白功能与对照新生儿相比

Zoë Vander Elst1,2, Thibault Stultjens3, Pieter Annaert4

  • 1Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Journal of clinical pharmacology
|February 11, 2025
PubMed
概括

新生儿患有缺氧缺血性脑病变 (HIE) 的治疗性低温症 (TH) 显著降低了人体血清白蛋白 (HSA) 水平. 这一发现对于优化接受HIE治疗的脆弱婴儿的药物剂量至关重要.

关键词:
药物结合 药物结合 药物结合人类血清白蛋白的人类血清白蛋白.缺氧 - 缺血性脑病变 - 脑病变这是新生儿新生儿.基于生理学的药理动力学.治疗性低温症 治疗性低温症

更多相关视频

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants11:39

Non-invasive Optical Measurement of Cerebral Metabolism and Hemodynamics in Infants

Published on: March 14, 2013

20.2K
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

909

相关概念视频

Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...